Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8 + T regulatory cells

Journal of Leukocyte Biology

Volumn 91, Issue 3, 2012, Pages 475-483

  Paunicka, Kathryn ^a   Chen, Peter W ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anterior chamber; Eye; Immune privilege; Interferon gamma; Local adoptive transfer

Indexed keywords

ALLOANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY;

ANIMAL CELL; ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN CELL;

ANIMALS; ANTERIOR CHAMBER; CD8-POSITIVE T-LYMPHOCYTES; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; INTERFERON-GAMMA; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 84863400509     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0311173     Document Type: Article

References (58)

1. Medawar, P. B. (1948) Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29, 58-69.
2. Fink, N., Stark, W. J., Maguire, M. G., Stulting, D., Meyer, R., Foulks, G., Smith, R. E., Rapoza, P. (1994) Effectiveness of histocompatibility matching in high-risk corneal transplantation: a summary of results from the Collaborative Corneal Transplantation Studies. Cesk. Oftalmol. 50, 3-12.
3. The Collaborative Corneal Transplantation Studies Research Group. (1992) The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch. Ophthalmol. 110, 1392-1403.
4. Barker, C. F., Billingham, R. E. (1977) Immunologically privileged sites. Adv. Immunol. 25, 1-54.
5. Niederkorn, J. Y., Streilein, J. W. (1982) Induction of anterior chamberassociated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases. J. Immunol. 128, 2470-2474.
6. Niederkorn, J. Y. (2007) The induction of anterior chamber-associated immune deviation. Chem. Immunol. Allergy 92, 27-35.
7. Streilein, J. W. (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3, 879-889.
8. Wilbanks, G. A., Streilein, J. W. (1990) Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71, 383-389.
9. D'Orazio, T. J., Mayhew, E., Niederkorn, J. Y. (2001) Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J. Immunol. 166, 26-32.
10. Chattopadhyay, S., O'Rourke, J., Cone, R. E. (2008) Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells. Int. Immunol. 20, 509-516.
11. Ashour, H. M., Niederkorn, J. Y. (2006) γδ T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. J. Immunol. 177, 8331-8337.
12. Skelsey, M. E., Mayhew, E., Niederkorn, J. Y. (2003) CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 110, 18-29.
13. D'Orazio, T. J., Niederkorn, J. Y. (1998) A novel role for TGF-β and IL-10 in the induction of immune privilege. J. Immunol. 160, 2089-2098.
14. Sonoda, K. H., Nakamura, T., Young, H. A., Hart, D., Carmeliet, P., Stein-Streilein, J. (2007) NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye. J. Immunol. 179, 2215-2222.
15. Cone, R. E., Chattopadhyay, S., O'Rourke, J. (2008) Control of delayedtype hypersensitivity by ocular-induced CD8+ regulatory T cells. Chem. Immunol. Allergy 94, 138-149.
16. Ren, Y., Yang, P., Li, B., Gao, Y., Zhou, H., Huang, X., Zhu, L., Kijlstra, A. (2006) OVA-specific CD8+ T cells do not express granzyme B during anterior chamber associated immune deviation. Graefes Arch. Clin. Exp. Ophthalmol. 244, 1315-1321.
17. D'Orazio, T. J., Niederkorn, J. Y. (1998) Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamberassociated immune deviation (ACAID). Immunology 95, 47-55.
18. Haring, J. S., Badovinac, V. P., Olson, M. R., Varga, S. M., Harty, J. T. (2005) In vivo generation of pathogen-specific Th1 cells in the absence of the IFN-γ receptor. J. Immunol. 175, 3117-3122.
19. Yoneda, Y., Hirota, R., Tashiro, J., Okada, M., Sakurai, K., Lee, K., Ueda, K., Kubota, T., Yoshida, R. (2003) Cellular origin of IFN-γ essential for hair cycle in normal skin. J. Interferon Cytokine Res. 23, 299-305.
20. Matthys, P., Vermeire, K., Billiau, A. (2001) Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-γ in autoimmune disease models. Trends Immunol. 22, 367-371.
21. Wang, Y., Goldschneider, I., O'Rourke, J., Cone, R. E. (2001) Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J. Leukoc. Biol. 69, 741-746.
22. Wilbanks, G. A., Streilein, J. W. (1992) Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg. Immunol. 4, 130-137.
23. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., Campbell, D. J. (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602.
24. Matthys, P., Vermeire, K., Mitera, T., Heremans, H., Huang, S., Schols, D., De Wolf-Peeters, C., Billiau, A. (1999) Enhanced autoimmune arthritis in IFN-γ receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J. Immunol. 163, 3503-3510.
25. Farrar, M. A., Schreiber, R. D. (1993) The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11, 571-611.
26. Wu, X., Hou, W., Sun, S., Bi, E., Wang, Y., Shi, M., Zang, J., Dong, C., Sun, B. (2006) Novel function of IFN-γ: negative regulation of dendritic cell migration and T cell priming. J. Immunol. 177, 934-943.
27. Hwu, P., Du, M. X., Lapointe, R., Do, M., Taylor, M. W., Young, H. A. (2000) Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164, 3596-3599.
28. Bugeon, L., Cuturi, M. C., Hallet, M. M., Paineau, J., Chabannes, D., Soulillou, J. P. (1992) Peripheral tolerance of an allograft in adult rats-characterization by low interleukin-2 and interferon-γ mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 54, 219-225.
29. Nickerson, P., Steiger, J., Zheng, X. X., Steele, A. W., Steurer, W., Roy-Chaudhury, P., Strom, T. B. (1997) Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation 63, 489-494.
30. Chan, S. Y., DeBruyne, L. A., Goodman, R. E., Eichwald, E. J., Bishop, D. K. (1995) In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 59, 1155-1161.
31. Zhang, J. (2007) Yin and yang interplay of IFN-γ in inflammation and autoimmune disease. J. Clin. Invest. 117, 871-873.
32. Wang, H., Asavaroengchai, W., Yeap, B. Y., Wang, M. G., Wang, S., Sykes, M., Yang, Y. G. (2009) Paradoxical effects of IFN-γ in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury. Blood 113, 3612-3619.
33. Cunnusamy, K., Paunicka, K., Reyes, N., Yang, W., Chen, P. W., Niederkorn, J. Y. (2010) Two different regulatory T cell populations that promote corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 51, 6566-6574.
34. Sis, B., Famulski, K. S., Allanach, K. L., Zhu, L. F., Halloran, P. F. (2007) IFN-γ prevents early perforin-granzyme-mediated destruction of kidney allografts by inducing donor class I products in the kidney. Am. J. Transplant. 7, 2301-2310.
35. Hargrave, S. L., Hay, C., Mellon, J., Mayhew, E., Niederkorn, J. Y. (2004) Fate of MHC-matched corneal allografts in Th1-deficient hosts. Invest. Ophthalmol. Vis. Sci. 45, 1188-1193.
36. Cunnusamy, K., Chen, P. W., Niederkorn, J. Y. (2010) IL-17 promotes immune privilege of corneal allografts. J. Immunol. 185, 4651-4658.
37. Sawitzki, B., Kieselbach, B., Fisser, M., Meisel, C., Vogt, K., Gaestel, M., Lehmann, M., Risch, K., Grutz, G., Volk, H. D. (2004) IFN-γ regulation in anti-CD4 antibody-induced T cell unresponsiveness. J. Am. Soc. Nephrol. 15, 695-703.
38. Nishibori, T., Tanabe, Y., Su, L., David, M. (2004) Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199, 25-34.
39. Wang, Z., Hong, J., Sun, W., Xu, G., Li, N., Chen, X., Liu, A., Xu, L., Sun, B., Zhang, J. Z. (2006) Role of IFN-γ in induction of Foxp3 and conversion of CD4+ CD25+ T cells to CD4+ Tregs. J. Clin. Invest. 116, 2434-2441.
40. Caspi, R. R., Chan, C. C., Grubbs, B. G., Silver, P. B., Wiggert, B., Parsa, C. F., Bahmanyar, S., Billiau, A., Heremans, H. (1994) Endogenous systemic IFN-γ has a protective role against ocular autoimmunity in mice. J. Immunol. 152, 890-899.
41. Jones, L. S., Rizzo, L. V., Agarwal, R. K., Tarrant, T. K., Chan, C. C., Wiggert, B., Caspi, R. R. (1997) IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158, 5997-6005.
42. Feng, G., Wood, K. J., Bushell, A. (2011) Regulatory T cell enrichment by IFN-γ conditioning. Methods Mol. Biol. 677, 281-301.
43. Myers, L., Croft, M., Kwon, B. S., Mittler, R. S., Vella, A. T. (2005) Peptide-specific CD8 T regulatory cells use IFN-γ to elaborate TGF-β-based suppression. J. Immunol. 174, 7625-7632.
44. Feng, G., Gao, W., Strom, T. B., Oukka, M., Francis, R. S., Wood, K. J., Bushell, A. (2008) Exogenous IFN-_ ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3_ regulatory T cells. Eur. J. Immunol. 38, 2512-2527.
45. Jiang, X. F., Zhu, L., Cui, Z. M., Guo, D. W., Sun, W. Y., Lin, L., Tang, Y. F., Wang, X. F., Liang, J. (2011) Transplant long-surviving induced by CD40-CD40 ligand costimulation blockade is dependent on IFN-γ through its effect on CD4(+)CD25(+) regulatory T cells. Transpl. Immunol. 24, 113-118.
46. Tang, X., Maricic, I., Purohit, N., Bakamjian, B., Reed-Loisel, L. M., Beeston, T., Jensen, P., Kumar, V. (2006) Regulation of immunity by a novel population of Qa-1-restricted CD8αα+ TCRαβ+ T cells. J. Immunol. 177, 7645-7655.
47. Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, H. Y., Suh, J. H., Choi, B. K., Vinay, D. S., Kwon, B. S. (2004) 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 10, 1088-1094.
48. Li, X. L., Menoret, S., Bezie, S., Caron, L., Chabannes, D., Hill, M., Halary, F., Angin, M., Heslan, M., Usal, C., Liang, L., Guillonneau, C., Le Mauff, B., Cuturi, M. C., Josien, R., Anegon, I. (2010) Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J. Immunol. 185, 823-833.
49. Monk, C. R., Spachidou, M., Rovis, F., Leung, E., Botto, M., Lechler, R. I., Garden, O. A. (2005) MRL/Mp CD4+, CD25+ T cells show reduced sensitivity to suppression by CD4+, CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum. 52, 1180-1184.
50. You, S., Belghith, M., Cobbold, S., Alyanakian, M. A., Gouarin, C., Barriot, S., Garcia, C., Waldmann, H., Bach, J. F., Chatenoud, L. (2005) Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54, 1415-1422.
51. Venigalla, R. K., Tretter, T., Krienke, S., Max, R., Eckstein, V., Blank, N., Fiehn, C., Ho, A. D., Lorenz, H. M. (2008) Reduced CD4+, CD25+ T cell sensitivity to the suppressive function of CD4+, CD25high, CD127+/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 58, 2120-2130.
52. Zhao, D., Zhang, C., Yi, T., Lin, C. L., Todorov, I., Kandeel, F., Forman, S., Zeng, D. (2008) In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood 112, 2129-2138.
53. Cone, R. E., Li, X., Sharafieh, R., O'Rourke, J., Vella, A. T. (2007) The suppression of delayed-type hypersensitivity by CD8+ regulatory T cells requires IFN-_. Immunology 120, 112-119.
54. Niederkorn, J. Y. (2006) Anterior chamber-associated immune deviation and its impact on corneal allograft survival. Curr. Opin. Organ Transpl. 11, 360-365.
55. Sonoda, Y., Streilein, J. W. (1993) Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J. Immunol. 150, 1727-1734.
56. Niederkorn, J. Y., Mellon, J. (1996) Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 37, 2700-2707.
57. She, S. C., Moticka, E. J. (1993) Ability of intracamerally inoculated Band T-cell enriched allogeneic lymphocytes to enhance corneal allograft survival. Int. Ophthalmol. 17, 1-7.
58. She, S. C., Steahly, L. P., Moticka, E. J. (1990) Intracameral injection of allogeneic lymphocytes enhances corneal graft survival. Invest. Ophthalmol. Vis. Sci. 31, 1950-1956.